$ADRX
ADARx Pharmaceuticals, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$15.75
▲+18.42%+$2.45Market open
ADARx Pharmaceuticals, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ADRX up today? It is at $15.75 (+18.42%), and our scanner flagged it 82 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ADRX spikes, and full due diligence on ADRX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ADRX 82 times in the last 30 days. Create a free account to track $ADRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
ADRX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on ADRX today, peaking at 7.0x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystUnregistered Share Sale · Other Material Event, from an SEC filing. Read it →Latest filingSC 13GPassive 5%+ stake disclosedOct 16, 2026 · 26 days agoA share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Lav Biosciences Fund V, L.P. Beneficial Owner (10%) | Acquired (grant/award) | +11.24M 11.0% of company | n/a | 11.24M | n/a | Sep 28, 26 |
Lav Biosciences Fund V, L.P. Beneficial Owner (10%) | Acquired (grant/award) | +615K 0.6% of company | n/a | 615K | n/a | Sep 28, 26 |
George Simeon Director | Acquired (grant/award) | +8.34M 8.2% of company | n/a | 4.96M | n/a | Sep 28, 26 |
George Simeon Director | Bought (open market) | +1.60M 1.6% of company | added 19% | 9.94M | $27.2M at $17.00 | Sep 28, 26 |
Sr One Capital Management, Llc Beneficial Owner (10%) | Acquired (grant/award) | +8.34M 8.2% of company | n/a | 4.96M | n/a | Sep 28, 26 |
Sr One Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +1.60M 1.6% of company | added 19% | 9.94M | $27.2M at $17.00 | Sep 28, 26 |
Orbimed Advisors Llc Director | Acquired (grant/award) | +23.26M 22.8% of company | n/a | 14.03M | n/a | Sep 28, 26 |
Orbimed Advisors Llc Director | Bought (open market) | +950K 0.9% of company | added 4.1% | 24.21M | $16.1M at $17.00 | Sep 28, 26 |
Gordon Carl L Director | Acquired (grant/award) | +23.26M 22.8% of company | n/a | 14.03M | n/a | Sep 28, 26 |
Gordon Carl L Director | Bought (open market) | +950K 0.9% of company | added 4.1% | 24.21M | $16.1M at $17.00 | Sep 28, 26 |
Chimovits Erez Director | Acquired (grant/award) | +9.23M 9.0% of company | n/a | 9.23M | n/a | Sep 28, 26 |
Chimovits Erez Director | Bought (open market) | +62K 0.06% of company | added 0.7% | 9.29M | $1.0M at $17.00 | Sep 28, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
ADRX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on ADRX today, peaking at 7.0x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
ADRX last traded at $15.75, up 18.42% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The ADRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ADRX 82 times in the last 30 days.
ADRX (ADARx Pharmaceuticals, Inc. Common Stock) trades on XNAS, with a market cap of about $1.36B in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ADRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ADRX discussion
Sign in to ask a question or join the discussion.